Key result
Published correction adds acknowledgment for use of the Newest Vital Sign tool in prior article.
Correction ensures proper NVS licensing attribution; leaves open any effect on original discharge education findings.
In the April 2026 article, “Out-the-Door, Dinosaur: Assessing Health Literacy to Improve Discharge Education” by de la Vega et al (Critical Care Nurse. 2026;46[2]: 47-53), the following acknowledgment should have been included:The NVS (Newest Vital Sign) was originally developed by Pfizer Inc. and is used under the license from Cronos Clinical Consulting Services, Inc. All licensing and permission request should be directed to IQVIA Inc at CoAsolutions@Iqvia.com.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question. This is a published correction adding an acknowledgment for the use of the Newest Vital Sign (NVS) tool in a previously published article.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: